Breakthrough: Regenerative Medicine Transforms Organ Repair
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease. LyGenesis, a … Continue reading "LyGenesis progresses Phase 2a clinical trial in...
